Analytical Lifecycle Management Under ICH Q14 and Q2(R2): What Changes Operationally

The implementation of ICH Q14 and the revised ICH Q2(R2) guidance is changing how organizations approach analytical method development, validation, transfer, maintenance, and lifecycle management. While many companies understand the principles described within the guidance documents, uncertainty often arises when translating those expectations into practical laboratory, quality, validation, and regulatory activities. Questions frequently emerge around method flexibility, development documentation, analytical control strategies, post-validation changes, and the evidence needed to support ongoing method performance throughout the product lifecycle.

This session examines the operational impact of ICH Q14 and Q2(R2) beyond the guidance language itself. The discussion will focus on how analytical lifecycle concepts influence method development decisions, validation strategies, change management activities, continued performance monitoring, and regulatory expectations. Practical examples will be used to explore how organizations can apply lifecycle principles while maintaining scientific rigor, operational efficiency, and regulatory compliance.

| WHY YOU SHOULD ATTEND

Historically, many methods were developed, validated, approved, and then treated as static objects. The problem is that methods continue to live for years, sometimes decades. Laboratories change, analysts change, equipment changes, products evolve, investigations occur, transfers happen, and performance drifts over time. Many of the most difficult analytical decisions arise long after the original validation work has been completed.

Organizations often discover that the greatest challenge is not generating validation data, but explaining why a method was designed a certain way, determining how much flexibility exists when changes become necessary, and deciding what evidence is required to support those changes. This session focuses on the operational and scientific judgment required to manage analytical methods throughout their lifecycle while maintaining confidence in method performance, regulatory compliance, and long-term sustainability.

| AREAS COVERED

• Determining What Evidence Is Sufficient During Analytical Method Development
• Establishing Method Flexibility Without Creating Regulatory Risk
• Defining Analytical Control Strategies That Support Lifecycle Management
• Determining When Method Changes Require Additional Validation or Justification
• Managing Method Transfer Challenges Across Laboratories and Sites
• Monitoring Ongoing Method Performance and Detecting Meaningful Drift
• Documentation and Evidence Supporting Defensible Lifecycle Decisions
• Operational Expectations Under ICH Q14 and Q2(R2) Throughout the Method Lifecycle

| WHO SHOULD ATTEND

• Analytical Development Scientists
• Quality Control (QC) Departments
• Quality Assurance (QA) Departments
• Laboratory Managers and Supervisors
• Validation and Qualification Professionals
• Regulatory Affairs Departments
• CMC and Technical Services Personnel
• Pharmaceutical and Biotechnology Manufacturing Professionals

Course Director: Meredith Crabtree

Meredith Crabtree has over 30 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.